Marijuana—Worse Than We Thought? The Benefits (And Risks) Of Weight-Loss Drugs episode artwork

EPISODE · Dec 14, 2022 · 30 MIN

Marijuana—Worse Than We Thought? The Benefits (And Risks) Of Weight-Loss Drugs

from ACSH Science Dispatch · host ACSH

A recent study found that marijuana smoke may cause emphysema. The problem? The study was complete garbage. Celebrities and social-media "influencers" are hyping the weight-loss benefits of repurposed diabetes drugs. Should these medicines really be used to slim down? It's complicated. Join host Cameron English as he sits down Dr. Chuck Dinerstein to break down these stories on episode 29 of the Science Dispatch podcast: Another Health Harm from Marijuana “In a new analysis of medical records, cannabis smokers had higher rates of a certain type of emphysema than tobacco smokers.” It's another attention-grabbing headline that fails to tell the whole story. Let’s skip the public relations version and consider the study's findings. Ozempic Goes Way Off-Label Ozempic, a drug indicated for Type 2 diabetes, has become the latest weight-loss darling. Not since ivermectin has a drug gained so much interest from its off-label uses. Let’s take a deeper look at the science and a regulatory conundrum.

Episode metadata supplied by the publisher feed · Published Dec 14, 2022

Embed this episode

NOW PLAYING

Marijuana—Worse Than We Thought? The Benefits (And Risks) Of Weight-Loss Drugs

0:00 30:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ACSH Science Dispatch?

This episode is 30 minutes long.

When was this ACSH Science Dispatch episode published?

This episode was published on December 14, 2022.

Can I download this ACSH Science Dispatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!